Neulastim Pre-filled Syringe 6mg0.6ml Singapore - English - HSA (Health Sciences Authority)

neulastim pre-filled syringe 6mg0.6ml

amgen biotechnology singapore pte ltd - pegfilgrastim - injection, solution - 6mg - pegfilgrastim 6mg/0.6ml

Neupopeg European Union - English - EMA (European Medicines Agency)

neupopeg

dompé biotec s.p.a. - pegfilgrastim - neutropenia; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

NEULASTIM Israel - English - Ministry of Health

neulastim

amgen europe b.v. - pegfilgrastim - solution for injection - pegfilgrastim 10 mg/ml ml - pegfilgrastim - pegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy. ( with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

PEGLASTA PRE-FILLED SYRINGE 6 mg/0.6 ml Singapore - English - HSA (Health Sciences Authority)

peglasta pre-filled syringe 6 mg/0.6 ml

kyowa hakko kirin (singapore) pte. ltd. - pegfilgrastim - injection, solution, concentrate - 6mg/0.6 ml

Neulasta European Union - English - EMA (European Medicines Agency)

neulasta

amgen europe b.v. - pegfilgrastim - neutropenia; cancer - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Ristempa European Union - English - EMA (European Medicines Agency)

ristempa

amgen europe b.v. - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes)

Pelgraz European Union - English - EMA (European Medicines Agency)

pelgraz

accord healthcare s.l.u. - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Fulphila European Union - English - EMA (European Medicines Agency)

fulphila

biosimilar collaborations ireland limited - pegfilgrastim - neutropenia - immunostimulants, - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Pelmeg European Union - English - EMA (European Medicines Agency)

pelmeg

mundipharma corporation (ireland) limited - pegfilgrastim - neutropenia - immunostimulants, - to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy.